Postprandial hyperglycemia
Conditions
Interventions
active food
placebo food
Sponsors
Anti-Aging Bank Co.,Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: [1]Aged between 20 and 49 [2]Individuals who are healthy and do not treat any disease [3]Individuals who feels that a blood sugar level is rather high [4]Individuals whose written informed consent has been obtained [5]Individuals who can have an examination on a designated check day [6]Individuals judged appropriate for the study by the principal
Exclusion criteria
Exclusion criteria: [1]Individuals using medical products [2]Individuals who are or are under treatment or have a history of Impaired Glucose Tolerance,mental disabilities,sleep disorder,hypertension,diabetes,fat metabolism or the other serious dysfunctions [3]Individuals who used a drug to treat in the past 1 month (One-shot medicine of a headache, menstrual pain and a cold removes it.) [4]Individuals who have a history of serious hepatopathy, kidney damage, heart disease, lung disease,or blood disease [5]Individual who have digestive organ disease(disease of an appendix is removed) [6]Individuals whose BMI is over 30 kg/m2 [7]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months [8]Individuals with serious anemia [9]Individuals who are sensitive to test products or Individual with fear who causes severe allergy in a food and medical supplies [10]Individual who is pregnant or lactate [11]Individual who is based on average alcohol per 1 day and exceeds 60g/day [12]Individuals whose life style will change during the test period (ex. travel for a long time) [13]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplyments of glycometabolism in the past 3 month or will ingest those foods during the test period [14]Individuals who participated in other clinical studies in the past three months [15]Individuals judged inappropriate for the study by the principal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postprandial blood glucose (0,15,30,45,60,90 and 120min) | — |
Secondary
| Measure | Time frame |
|---|---|
| Postprandial Insulin (0,15,30,45,60,90 and 120min) Postprandial Glucagon (0,15,30,45,60,90 and 120min) Postprandial Triglyceride (0,15,30,45,60,90 and 120min) Non-esterified fatty acid (0,15,30,45,60,90 and 120min) | — |
Countries
Japan
Contacts
Public ContactToshiyasu Tamura
TES Holdings Co., Ltd. Department of Clinical Trial
Outcome results
None listed